PNT - POINT Biopharma Global GAAP EPS of -$0.16 beats by $0.12 March, 25 2022 09:08 AM POINT Biopharma Global Inc. POINT Biopharma Global press release (NASDAQ:PNT): Q4 GAAP EPS of -$0.16 beats by $0.12. As of December 31, 2021, cash and cash equivalents of $238.8M For further details see: POINT Biopharma Global GAAP EPS of -$0.16 beats by $0.12